Sort   by:  
 Page size 
UnknownAn Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma.
Not available
S-EPMC12498259 | biostudies-literature
UnknownThe Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
Not available
S-EPMC7884404 | biostudies-literature
UnknownSingle-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer.
Not available
S-EPMC11525017 | biostudies-literature
UnknownJAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Not available
S-EPMC10905886 | biostudies-literature
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
UnknownStandard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Not available
S-EPMC4648090 | biostudies-literature
UnknownTiming of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer.
Not available
S-EPMC11258338 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownSmall-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.
Not available
S-EPMC10711013 | biostudies-literature
Sort   by:  
 Page size